Researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI) and Southern Alberta Cancer Research Institute (SACRI) have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Brain Canada to fund six projects - over $7.4 million for brain and mental health
The announcement was made today in Calgary by Rupert Duchesne, Chair of Brain Canada, for funding that comes from the Canada Brain Research Fund. The Government of Canada, through the Canada Brain Research Fund, provides half of the funding for the projects. The other half is provided by private donors, research institutes, provincial funding agencies, and charitable organizations partnering with the Brain Canada Foundation.
The HBI is pleased to welcome Dr. Oury Monchi, the Tourmaline Oil Chair in Parkinson's disease. Dr. Monchi has been a pioneer in using different neuroimaging techniques to study the origins and evolution of cognitive deficits in Parkinson's disease with the ultimate goal of the early prediction of dementia in the disease.